BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 2, 2012
View Archived Issues
New claudin-6-binding antibodies patented in Germany
Read More
Novel platinum(IV) complexes disclosed by Universidad Autonoma de Madrid
Read More
Allergan presents novel agents for ocular disorders
Read More
Galderma Pharma prepares new agent for rosacea
Read More
New human papillomavirus vaccines developed in China
Read More
Novel orexin OX receptor antagonists discovered at Actelion Pharmaceuticals
Read More
New mechanism of action reveals potential of salirasib to treat rare lung disorder
Read More
Two-gene signature predicts prognosis of previously untreated chronic lymphocytic leukemia
Read More
Shire and Sangamo BioSciences enter agreement for hemophilia therapeutics
Read More
IDRI contributes to Sabin Vaccine Institute's first-ever hookworm vaccine study
Read More
Boehringer Ingelheim selects Nanobody candidate from Ablynx alliance
Read More
ThromboGenics plans to resubmit ocriplasmin BLA for priority review
Read More
Study identifies new therapeutic target for refractory inflammation in COPD
Read More
Impax Pharmaceuticals gains U.S. rights to migraine therapy
Read More
FDA advisory committee sets review date for lorcaserin NDA resubmission
Read More
U.S. team designs new nanoparticle delivery systems to target chemotherapy to cancer cells
Read More
Phase III tuberculosis trial completes enrollment
Read More
Eusa Pharma acquires Asparec rights
Read More
Phase III lubiprostone study meets primary endpoint
Read More
New gene expression signature predicts outcome of patients with basal-like breast cancer
Read More
Boston Scientific launches Promus Element Plus stent system in Europe
Read More
Navidea Biopharmaceuticals receives CHMP advice on Lymphoseek MAA
Read More
Dosing begins in phase II AFN-1252 study in ABSSSI
Read More
WHO releases roadmap for work to eliminate neglected tropical diseases
Read More
Athersys receives grant to develop stem cell therapy for traumatic brain injury
Read More